ES2177250T3 - Sales de cetoacidos y de derivados aminas, y su utilizacion para la preparacion de medicamentos. - Google Patents
Sales de cetoacidos y de derivados aminas, y su utilizacion para la preparacion de medicamentos.Info
- Publication number
- ES2177250T3 ES2177250T3 ES99907688T ES99907688T ES2177250T3 ES 2177250 T3 ES2177250 T3 ES 2177250T3 ES 99907688 T ES99907688 T ES 99907688T ES 99907688 T ES99907688 T ES 99907688T ES 2177250 T3 ES2177250 T3 ES 2177250T3
- Authority
- ES
- Spain
- Prior art keywords
- amino acid
- preparation
- cetoacidos
- aminas
- medicines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 210000000013 bile duct Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 150000004715 keto acids Chemical class 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 229920000768 polyamine Polymers 0.000 abstract 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 abstract 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 abstract 1
- 125000001302 tertiary amino group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Utilización de compuestos de fórmula general (I) siguiente: (X)n1,Y,(Z)n2 (I) en la cual: n1 y n2 representa 0 ó 1, bajo reserva de que cuando n1=0, entonces n2=1, y que cuando n2=0 entonces n1=1, X representa un aminoácido natural, bajo reserva de que cuando n2=0, entonces X representa un aminoácido básico, Y representa un cetoácido de fórmula (II) siguiente R-CO-COOH (II) en la cual R representa un grupo alquilo o ácido alcanoico, sustituido o no, de 1 a 10 átomos de carbono, Z representa un aminoácido natural, o una poliamina que comprende por lo menos dos funciones aminas primarias, secundarias o terciarias, separada por una cadena hidrocarbonada lineal o ramificada de 3 a 10 átomos de carbono, para la preparación de un medicamento destinado al tratamiento de patologías humanas o animales en las cuales están implicadas las neuronas silenciosas, tales como las patologías del tubo digestivo, de la vejiga y de las vías biliares.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9803155A FR2775901B1 (fr) | 1998-03-13 | 1998-03-13 | Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2177250T3 true ES2177250T3 (es) | 2002-12-01 |
Family
ID=9524054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99907688T Expired - Lifetime ES2177250T3 (es) | 1998-03-13 | 1999-03-11 | Sales de cetoacidos y de derivados aminas, y su utilizacion para la preparacion de medicamentos. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6429229B1 (es) |
| EP (1) | EP1061909B1 (es) |
| JP (1) | JP2002506816A (es) |
| AR (1) | AR014714A1 (es) |
| AT (1) | ATE218335T1 (es) |
| AU (1) | AU2733699A (es) |
| BR (1) | BR9909651A (es) |
| DE (1) | DE69901689T2 (es) |
| DK (1) | DK1061909T3 (es) |
| DZ (1) | DZ2743A1 (es) |
| EG (1) | EG24397A (es) |
| ES (1) | ES2177250T3 (es) |
| FR (1) | FR2775901B1 (es) |
| HK (1) | HK1035856A1 (es) |
| MA (1) | MA24775A1 (es) |
| PT (1) | PT1061909E (es) |
| TN (1) | TNSN99032A1 (es) |
| TW (1) | TWI235059B (es) |
| WO (1) | WO1999047134A1 (es) |
| ZA (1) | ZA991982B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060128806A1 (en) * | 1998-05-28 | 2006-06-15 | Medical Research Institute | Controlled release arginine alpha-ketoglutarate |
| US20040039057A1 (en) * | 2000-09-19 | 2004-02-26 | Perlmutter Alan L. | Topical analgesic compositions containing aliphatic polyamines and methods of using same |
| FR2822704B1 (fr) * | 2001-03-29 | 2005-02-18 | Chiesi Sa | Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments |
| US7122578B2 (en) * | 2001-09-11 | 2006-10-17 | Alain Martin | Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration |
| PL372183A1 (pl) * | 2005-01-11 | 2006-07-24 | Sgp & Sons Ab | Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego |
| US20110105617A1 (en) * | 2005-01-11 | 2011-05-05 | Sgp & Sons Ab | Method for treatment of neoplastic diseases with alpha-keto glutarate and/or salts thereof |
| WO2009116546A1 (ja) * | 2008-03-18 | 2009-09-24 | 国立大学法人 岡山大学 | 興奮性化学伝達調節剤およびそのスクリーニング法 |
| FR2953719A1 (fr) * | 2009-12-10 | 2011-06-17 | Luc Cynober | Nouvelles applications therapeutiques d'un complexe d'alpha-cetoglutarate et d'ornithine |
| SI2523669T1 (sl) * | 2010-01-11 | 2017-05-31 | Inotek Pharmaceuticals Corporation | Kombinacija, komplet in metoda za zmanjšanje intraokularnega tlaka |
| BR112012023749A2 (pt) | 2010-03-26 | 2016-08-23 | Inotek Pharmaceuticals Corp | método para reduzir a pressão intraocular em humanos utilizando n6-ciclopentiladenosina (cpa), derivados de cpa ou pró-fármacos desses |
| KR20140128974A (ko) | 2012-01-26 | 2014-11-06 | 이노텍 파마슈티컬스 코포레이션 | ((2r,3s,4r,5r)-5-(6-(시클로펜틸아미노)-9h-퓨린-9-일)-3,4-디히드록시테트라히드로푸란-2-일) 메틸 니트레이트의 무수 다형체들 및 이들의 제조 방법들 |
| US20140187815A1 (en) * | 2012-12-28 | 2014-07-03 | Guoji Zhang | Process for preparation of l-arginine alpha-ketoglutarate 1:1 and 2:1 |
| SG11201506882YA (en) | 2013-03-15 | 2015-09-29 | Inotek Pharmaceuticals Corp | Ophthalmic formulations |
| EP3062766A1 (en) * | 2013-10-29 | 2016-09-07 | L'Oreal, S.A. | Use of mono ornithine ketoglutarate (mokg) |
| CN106674057A (zh) * | 2015-11-09 | 2017-05-17 | 江西乐维生物药业有限公司 | L-精氨酸a-酮基异己酸盐的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3533M (fr) * | 1964-03-05 | 1965-09-13 | Logeais Labor Jacques | Médicament pour le traitement des intoxications ammoniacales a base d'α-cétoglutarate de l (+) ornithine. |
| US4320146A (en) * | 1978-03-17 | 1982-03-16 | The Johns Hopkins University | Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids |
| DE3438455A1 (de) * | 1984-10-19 | 1986-06-26 | Institut Dr. Ziegler, Bettingen | L-lysin- und l-histidinpyruvat |
| US4957938A (en) * | 1989-06-21 | 1990-09-18 | Abbott Laboratories | Nutritional formulation for the treatment of renal disease |
-
1998
- 1998-03-13 FR FR9803155A patent/FR2775901B1/fr not_active Expired - Fee Related
-
1999
- 1999-03-04 TN TNTNSN99032A patent/TNSN99032A1/fr unknown
- 1999-03-09 MA MA25487A patent/MA24775A1/fr unknown
- 1999-03-10 DZ DZ990044A patent/DZ2743A1/xx active
- 1999-03-10 TW TW088103682A patent/TWI235059B/zh not_active IP Right Cessation
- 1999-03-11 US US09/646,059 patent/US6429229B1/en not_active Expired - Fee Related
- 1999-03-11 JP JP2000536374A patent/JP2002506816A/ja active Pending
- 1999-03-11 PT PT99907688T patent/PT1061909E/pt unknown
- 1999-03-11 AU AU27336/99A patent/AU2733699A/en not_active Abandoned
- 1999-03-11 EP EP99907688A patent/EP1061909B1/fr not_active Expired - Lifetime
- 1999-03-11 BR BR9909651-0A patent/BR9909651A/pt not_active IP Right Cessation
- 1999-03-11 DK DK99907688T patent/DK1061909T3/da active
- 1999-03-11 AT AT99907688T patent/ATE218335T1/de not_active IP Right Cessation
- 1999-03-11 ES ES99907688T patent/ES2177250T3/es not_active Expired - Lifetime
- 1999-03-11 DE DE69901689T patent/DE69901689T2/de not_active Expired - Fee Related
- 1999-03-11 ZA ZA9901982A patent/ZA991982B/xx unknown
- 1999-03-11 WO PCT/FR1999/000545 patent/WO1999047134A1/fr active IP Right Grant
- 1999-03-12 AR ARP990101081A patent/AR014714A1/es not_active Application Discontinuation
- 1999-03-13 EG EG26199A patent/EG24397A/xx active
-
2001
- 2001-06-27 HK HK01104440A patent/HK1035856A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1035856A1 (en) | 2001-12-14 |
| DK1061909T3 (da) | 2002-09-23 |
| JP2002506816A (ja) | 2002-03-05 |
| EP1061909A1 (fr) | 2000-12-27 |
| EG24397A (en) | 2009-04-27 |
| TNSN99032A1 (fr) | 2005-11-10 |
| MA24775A1 (fr) | 1999-10-01 |
| PT1061909E (pt) | 2002-11-29 |
| AU2733699A (en) | 1999-10-11 |
| BR9909651A (pt) | 2000-11-21 |
| DE69901689D1 (de) | 2002-07-11 |
| EP1061909B1 (fr) | 2002-06-05 |
| TWI235059B (en) | 2005-07-01 |
| AR014714A1 (es) | 2001-03-28 |
| ZA991982B (en) | 1999-11-23 |
| DZ2743A1 (fr) | 2004-09-05 |
| FR2775901A1 (fr) | 1999-09-17 |
| US6429229B1 (en) | 2002-08-06 |
| WO1999047134A1 (fr) | 1999-09-23 |
| DE69901689T2 (de) | 2003-01-30 |
| FR2775901B1 (fr) | 2000-07-21 |
| ATE218335T1 (de) | 2002-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2177250T3 (es) | Sales de cetoacidos y de derivados aminas, y su utilizacion para la preparacion de medicamentos. | |
| CY1119148T1 (el) | Φαρμακευτικες συνθεσεις και συναφεις μεθοδοι χορηγησης | |
| BR0015026A (pt) | Indóis substituìdos para a modulação da atividade de nfkb | |
| BR0316606A (pt) | Derivados de aminoindazóis e sua utilização como inibidores de quinases | |
| BR9913288A (pt) | Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico | |
| BR0115411A (pt) | Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares | |
| CY1113766T1 (el) | Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων | |
| BRPI0515546A (pt) | compostos para inflamação e usos imune-relacionados | |
| BR0016935A (pt) | Uso de derivados de ácido fumárico para tratamento de doenças mitocondriais | |
| UY27092A1 (es) | Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen | |
| EA200601802A1 (ru) | Производные морфолина | |
| ATE469674T1 (de) | 5-aminolävulinsäure-derivate zur behandlung von akne | |
| AR036448A1 (es) | Composiciones farmaceuticas de conjugados droga insulina-oligomeros, y metodos para tratar las enfermedades con los mismos | |
| EA200970287A1 (ru) | Способы, соединения, композиции и носители, подходящие для доставки 3-амино-1-пропансульфоновой кислоты | |
| UY28123A1 (es) | Nuevos derivados de fluoroglicósidos aromáticos, medicamentos que contienen estos compuestos y sus usos. | |
| AR025444A1 (es) | Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos | |
| AR020662A1 (es) | Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento. | |
| PE20050822A1 (es) | Derivados de florfenicol con mejor solubilidad en agua | |
| UY27619A1 (es) | Ésteres hidroxamato del ácido n-(4-fenil sustituido)- antranílico | |
| AR024944A1 (es) | Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion | |
| BR0008403A (pt) | Formulação farmacêutica para administração oral | |
| AR050908A1 (es) | Uso de benzopiranonas trisustituidas | |
| PT1339407E (pt) | Inibidores da proteina farnesil transferase para o tratamento de doenca inflamatoria do intestino | |
| UY25356A1 (es) | Polisacaridos de sintesis,procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| DK1560575T3 (da) | 3,5,3'-triiodthyroninsulfat som thyromimetisk middel og farmaceutiske formuleringer deraf |